Himension Capital Singapore PTE. LTD. Acquires 9,394 Shares of Synopsys, Inc. (NASDAQ:SNPS)

Himension Capital Singapore PTE. LTD. grew its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 50.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,909 shares of the semiconductor company's stock after buying an additional 9,394 shares during the quarter. Synopsys accounts for about 0.9% of Himension Capital Singapore PTE. LTD.'s investment portfolio, making the stock its 14th biggest holding. Himension Capital Singapore PTE. LTD.'s holdings in Synopsys were worth $13,546,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently made changes to their positions in the company. Caprock Group LLC boosted its stake in Synopsys by 0.5% in the 4th quarter. Caprock Group LLC now owns 3,714 shares of the semiconductor company's stock worth $1,803,000 after purchasing an additional 20 shares during the period. Compagnie Lombard Odier SCmA lifted its holdings in shares of Synopsys by 1.1% in the fourth quarter. Compagnie Lombard Odier SCmA now owns 1,850 shares of the semiconductor company's stock valued at $898,000 after purchasing an additional 20 shares in the last quarter. Edge Capital Group LLC boosted its position in shares of Synopsys by 1.2% during the fourth quarter. Edge Capital Group LLC now owns 1,629 shares of the semiconductor company's stock worth $791,000 after buying an additional 20 shares during the period. Barden Capital Management Inc. grew its holdings in shares of Synopsys by 1.1% during the fourth quarter. Barden Capital Management Inc. now owns 1,832 shares of the semiconductor company's stock worth $889,000 after buying an additional 20 shares in the last quarter. Finally, Hazlett Burt & Watson Inc. grew its holdings in shares of Synopsys by 28.6% during the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock worth $44,000 after buying an additional 20 shares in the last quarter. Institutional investors own 85.47% of the company's stock.

Remove Ads

Synopsys Stock Up 2.8 %

Shares of NASDAQ SNPS traded up $11.52 during midday trading on Friday, hitting $418.41. 821,822 shares of the company's stock were exchanged, compared to its average volume of 1,302,906. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $624.80. The company's 50 day moving average price is $459.56 and its 200 day moving average price is $498.75. The firm has a market capitalization of $64.69 billion, a PE ratio of 28.82, a price-to-earnings-growth ratio of 3.23 and a beta of 1.23.

Insider Activity

In other news, insider Geus Aart De sold 15,705 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the sale, the insider now owns 116,671 shares in the company, valued at $51,850,925.82. The trade was a 11.86 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the transaction, the chief executive officer now owns 70,922 shares in the company, valued at approximately $32,890,077.50. This trade represents a 13.81 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 47,909 shares of company stock valued at $22,794,835 over the last ninety days. 0.62% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Needham & Company LLC reaffirmed a "buy" rating and set a $650.00 price target on shares of Synopsys in a research report on Thursday, February 27th. Piper Sandler reduced their target price on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. Rosenblatt Securities reaffirmed a "buy" rating and issued a $660.00 target price on shares of Synopsys in a research report on Tuesday, February 25th. Wells Fargo & Company cut their price target on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 27th. Finally, Redburn Atlantic began coverage on Synopsys in a report on Monday, January 13th. They issued a "buy" rating and a $600.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $638.58.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.